Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,499 | 188 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $785.21 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $691.89 | 35 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $341.21 | 15 | $0 (2024) |
| UCB, Inc. | $173.03 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $165.30 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $143.94 | 8 | $0 (2024) |
| PFIZER INC. | $126.21 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.26 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $96.49 | 5 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $90.16 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $426.92 | 19 | UCB, Inc. ($92.67) |
| 2023 | $730.85 | 30 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($114.37) |
| 2022 | $202.29 | 12 | Janssen Pharmaceuticals, Inc ($101.26) |
| 2021 | $288.48 | 18 | Janssen Pharmaceuticals, Inc ($150.74) |
| 2020 | $251.21 | 14 | Janssen Pharmaceuticals, Inc ($111.14) |
| 2019 | $594.75 | 37 | Janssen Pharmaceuticals, Inc ($154.20) |
| 2018 | $403.89 | 24 | Novartis Pharmaceuticals Corporation ($199.92) |
| 2017 | $600.82 | 34 | Novartis Pharmaceuticals Corporation ($267.92) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Neurology | ||||||
| 10/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 05/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Gastroenterology | ||||||
| 05/02/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: CRITICAL CARE | ||||||
| 04/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Neurology | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Gastroenterology | ||||||
| 03/11/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: CRITICAL CARE | ||||||
| 02/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Neurology | ||||||
| 02/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Hematology | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Gastroenterology | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Gastroenterology | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Gastroenterology | ||||||
| 12/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $38.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 10/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 549 | 888 | $218,633 | $77,305 |
| 2022 | 7 | 501 | 841 | $171,221 | $63,510 |
| 2021 | 6 | 418 | 649 | $132,323 | $53,988 |
| 2020 | 7 | 420 | 769 | $149,313 | $63,263 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 185 | 431 | $111,919 | $40,895 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 209 | $37,602 | $12,845 | 34.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 86 | $38,356 | $11,532 | 30.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 91 | 91 | $21,554 | $8,249 | 38.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 42 | 42 | $6,663 | $2,664 | 40.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 29 | $2,539 | $1,119 | 44.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 170 | 384 | $85,542 | $30,903 | 36.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 117 | 238 | $35,318 | $13,517 | 38.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 97 | 98 | $21,478 | $8,151 | 38.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 46 | $18,891 | $7,136 | 37.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 44 | 44 | $6,512 | $2,455 | 37.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 15 | 15 | $2,234 | $856.11 | 38.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 16 | $1,246 | $491.61 | 39.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 128 | 290 | $58,870 | $24,138 | 41.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 69 | 69 | $27,393 | $11,293 | 41.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 90 | 157 | $22,137 | $9,080 | 41.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 71 | 73 | $15,403 | $6,086 | 39.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 43 | 43 | $6,106 | $2,410 | 39.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 17 | 17 | $2,414 | $981.75 | 40.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 138 | 363 | $73,689 | $31,638 | 42.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 109 | 227 | $32,007 | $13,734 | 42.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 51 | 51 | $20,247 | $7,866 | 38.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 60 | 60 | $12,660 | $5,520 | 43.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 37 | 37 | $5,254 | $2,263 | 43.1% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 11 | 17 | $3,468 | $1,415 | 40.8% |
About Dr. David Watson, MD
Dr. David Watson, MD is a Internal Medicine healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1629255294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Watson, MD has received a total of $3,499 in payments from pharmaceutical and medical device companies, with $426.92 received in 2024. These payments were reported across 188 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,499).
As a Medicare-enrolled provider, Watson has provided services to 1,888 Medicare beneficiaries, totaling 3,147 services with total Medicare billing of $258,066. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Atlanta, GA
- Active Since 01/26/2008
- Last Updated 10/30/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629255294
Products in Payments
- XARELTO (Drug) $785.21
- ENTRESTO (Drug) $646.50
- XIFAXAN (Drug) $309.04
- ELIQUIS (Drug) $200.24
- Briviact (Drug) $173.03
- JARDIANCE (Drug) $94.12
- PATIENT MONITOR (Device) $86.96
- DIFICID (Drug) $80.67
- GVOKE HYPOPEN (Drug) $72.83
- SAMSCA (Drug) $72.33
- RELISTOR (Drug) $61.57
- Orbactiv (Drug) $55.04
- TERLIVAZ (Drug) $50.01
- LEQVIO (Drug) $45.39
- FARXIGA (Drug) $44.49
- LifeVest (Device) $39.78
- GATTEX (Drug) $38.53
- BEVESPI AEROSPHERE (Drug) $37.78
- TEFLARO (Drug) $33.67
- MINOCIN IV (Drug) $32.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atlanta
Dr. Nitin Gupta, M.d, M.D
Internal Medicine — Payments: $1.2M
Dr. Zandraetta Tims-Cook, Md, Mph, MD, MPH
Internal Medicine — Payments: $648,799
Brian Pearlman, Md, MD
Internal Medicine — Payments: $588,483
Tracey Henry
Internal Medicine — Payments: $304,663
Michael Lloyd, Md, MD
Internal Medicine — Payments: $276,236
Mr. Robert Springer, M.d, M.D
Internal Medicine — Payments: $243,195